TrialNet: Natural History Study of the Development of Type 1 Diabetes.
Study Timeline: Currently open to enrollment
This study is designed to screen for certain antibodies in the blood know to be associated with risk of type 1 diabetes. Eligible participants receive a small blood draw as a baseline screening. Repeat assessments may be done depending on the presence of target antibodies. To find out more about TrialNet studies, click here.
